This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William J. Quinones-Baldrich, MD; Vicente Martin-Paredero, MD, PhD; J. Dennis Baker, MD; Ronald W. Busuttil, MD, PhD; Herbert I. Machleder, MD; Wesley S. Moore, MD

Arch Surg. 1984;119(11):1238-1243.

Abstract
• We studied a series of femoropopliteal bypass operations in which polytetrafluoroethylene (PTFE) grafts were used as the first choice, regardless of the availability of saphenous vein. From Jan 1, 1979 to Dec 31,1982,63 PTFE femoropopliteal bypass grafts were placed in 55 patients without exploration of the saphenous vein. Forty-three grafts were placed for limb salvage, and 20 grafts were placed for disabling claudication. Patients were followed up for nine to 53 months (average, 23 months). The operative mortality was 1.8%. There were no infections. The overall patency at 30 months was 76.1%. The 30 months' cumulative patency rate for patients with claudication was 89.3%, and there were no amputations. The cumulative 30-month patency for limb salvage was 70.1%, and there was a limb salvage rate of 81.2%. Because the 30-month results were comparable with reported series using autogenous saphenous vein, we concluded that PTFE conduits may be considered the first-choice arterial substitute for femoropopliteal reconstruction. Until longer follow-ups are available, reversed autogenous saphenous vein should probably be the graft of first choice in younger patients (less than 60 years of age) without coronary artery disease who are undergoing femoropopliteal revascularizations.

(Arch Surg 1984;119:1238-1243)

Author Affiliations
From the Department of Surgery, UCLA School of Medicine.

Footnotes
Accepted for publication July 2, 1984.

Read before the Annual Meeting of the Southern California Chapter of the American College of Surgeons, Santa Barbara, Calif, Jan 27, 1984.

Reprint requests to Room 72-160 CHS, Department of Surgery, UCLA School of Medicine, Los Angeles, CA 90024 (Dr Moore).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Noninvasive Measurement of Shear Rate in Autologous and Prosthetic Bypass Grafts
Setty et al.
VASC ENDOVASCULAR SURG 2002;36:447-455.
ABSTRACT  

A Polymeric Sealant Inhibits Anastomotic Suture Hole Bleeding More Rapidly Than Gelfoam/Thrombin: Results of a Randomized Controlled Trial
Glickman et al.
Arch Surg 2002;137:326-331.
ABSTRACT | FULL TEXT  

The Choice of Material for Above-Knee Femoropopliteal Bypass: A 20-Year Experience
Berlakovich et al.
Arch Surg 1994;129:297-302.
ABSTRACT  

Polytetrafluoroethylene Grafts in Infrainguinal Arterial Revascularization: Factors Affecting Outcome
AbuRahma et al.
Arch Surg 1993;128:417-422.
ABSTRACT  

Ten-year Follow-up of Femoropopliteal Bypass Grafts: Comparative Review of Late Patency Rates of PTFE and Saphenous Vein Grafts for Lower Extremity Ischemia
Dayioglu et al.
VASC ENDOVASCULAR SURG 1992;26:369-376.
ABSTRACT  

The Possibility of Distal Embolization From a Femoral-Popliteal Prosthesis Above the Knee: A Consideration Against Its Routine Use in This Position
Friedman and Krishnasastry
Arch Surg 1990;125:668-670.
ABSTRACT  

The Dacron EXS Graft for Femoropopliteal Arterial Reconstruction
Matsubara et al.
VASC ENDOVASCULAR SURG 1989;23:280-285.
ABSTRACT  

Polytetrafluoroethylene Grafts for Leg Ischemia: Facts and Fiction-Reply
QUINONES-BALDRICH and MOORE
Arch Surg 1985;120:1089-1089.
ABSTRACT  

Polytetrafluoroethylene Grafts for Leg Ischemia: Facts and Fiction
CAMPO
Arch Surg 1985;120:1088-1089.
ABSTRACT